LENSAR Q1 revenue $14.2M (+34% YoY); net loss $27.3M on warrant liability

LENSAR, Inc.

2025-Q1 EPS reported -$2.32 revenue$14,159,000

Total revenue $14.2M vs $10.6M in Q1 2024, driven by system sales and 33% procedure volume growth.
Net loss $27.3M ($2.32/share) vs $2.2M loss YoY; increase primarily from warrant liability revaluation due to 58% stock price rise.
Adjusted EBITDA was $0.2M vs -$1.3M in Q1 2024; includes $4.2M in Alcon merger-related costs.
Placed 14 ALLY systems in Q1; total installed base ~395 systems, up 26% YoY.
Recurring revenue $11.5M (81% of total); procedure volume 52,347 worldwide, up 33% YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.